There are two massive opportunities, one in distribution, one in devices, that might greatly benefit DECN but until they show definitive proof of being able to execute, I won't be sharing either. These windows will likely close in 2018, coincidentally. So there is an opportunity cost to pretending a lack of results is somehow strategic.
(0)
(1)
Decision Diagnostics Corp (DECN) Stock Research Links